GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (STU:DMP) » Definitions » Shiller PE Ratio

Dermapharm Holding SE (STU:DMP) Shiller PE Ratio : 21.08 (As of Jun. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Shiller PE Ratio?

As of today (2024-06-16), Dermapharm Holding SE's current share price is €36.25. Dermapharm Holding SE's E10 for the fiscal year that ended in Dec23 was €1.72. Dermapharm Holding SE's Shiller PE Ratio for today is 21.08.

The historical rank and industry rank for Dermapharm Holding SE's Shiller PE Ratio or its related term are showing as below:

STU:DMP' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.38   Med: 22.3   Max: 23.88
Current: 21.2

During the past 11 years, Dermapharm Holding SE's highest Shiller PE Ratio was 23.88. The lowest was 19.38. And the median was 22.30.

STU:DMP's Shiller PE Ratio is ranked better than
54.95% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.58 vs STU:DMP: 21.20

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dermapharm Holding SE's adjusted earnings per share data of for the fiscal year that ended in Dec23 was €1.160. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €1.72 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dermapharm Holding SE Shiller PE Ratio Historical Data

The historical data trend for Dermapharm Holding SE's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Shiller PE Ratio Chart

Dermapharm Holding SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 21.90 24.57

Dermapharm Holding SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 24.57 -

Competitive Comparison of Dermapharm Holding SE's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dermapharm Holding SE's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Shiller PE Ratio falls into.



Dermapharm Holding SE Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dermapharm Holding SE's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=36.25/1.72
=21.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dermapharm Holding SE's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Dermapharm Holding SE's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.16/123.7729*123.7729
=1.160

Current CPI (Dec23) = 123.7729.

Dermapharm Holding SE Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -0.001 99.543 -0.001
201512 0.236 99.717 0.293
201612 1.430 101.217 1.749
201712 1.560 102.617 1.882
201812 1.410 104.217 1.675
201912 1.430 105.818 1.673
202012 1.590 105.518 1.865
202112 3.890 110.384 4.362
202212 2.490 119.345 2.582
202312 1.160 123.773 1.160

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dermapharm Holding SE  (STU:DMP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dermapharm Holding SE Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dermapharm Holding SE (STU:DMP) Business Description

Traded in Other Exchanges
Address
Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Dermapharm Holding SE (STU:DMP) Headlines

No Headlines